PET imaging agents (Bayer/ETH Zurich)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePET imaging agents (Bayer/ETH Zurich)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9Matrix metalloproteinase-2
Therapy Area/IndicationsAtherosclerosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSwiss Federal Institute Of Technology ZurichBayer AG
Active IndicationsN/A
Inactive IndicationsAtherosclerosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A